Welcome to LookChem.com Sign In|Join Free
  • or
N,9-Diacetylguanine, also known as Acicclovir EP Impurity L, is a white or brownish crystalline powder with specific chemical properties. It is a significant compound in the field of pharmaceuticals, particularly for the synthesis of acyclic analogues of deoxyguanosine.

3056-33-5

Post Buying Request

3056-33-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3056-33-5 Usage

Uses

Used in Pharmaceutical Industry:
N,9-Diacetylguanine is used as a key intermediate for the synthesis of acyclic analogues of deoxyguanosine. These analogues are essential in the development of antiviral medications, particularly those targeting herpes simplex virus (HSV) and other related viral infections. N,9-Diacetylguanine plays a crucial role in the pharmaceutical industry by contributing to the creation of effective antiviral drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 3056-33-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,5 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3056-33:
(6*3)+(5*0)+(4*5)+(3*6)+(2*3)+(1*3)=65
65 % 10 = 5
So 3056-33-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H9N5O3/c1-4(15)11-9-12-7-6(8(17)13-9)10-3-14(7)5(2)16/h3H,1-2H3,(H2,11,12,13,15,17)

3056-33-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D3604)  N2,9-Diacetylguanine  >95.0%(T)

  • 3056-33-5

  • 25g

  • 555.00CNY

  • Detail
  • Alfa Aesar

  • (B22709)  N(2),9-Diacetylguanine, 99%   

  • 3056-33-5

  • 5g

  • 613.0CNY

  • Detail
  • Alfa Aesar

  • (B22709)  N(2),9-Diacetylguanine, 99%   

  • 3056-33-5

  • 25g

  • 2605.0CNY

  • Detail
  • Alfa Aesar

  • (B22709)  N(2),9-Diacetylguanine, 99%   

  • 3056-33-5

  • 100g

  • 8858.0CNY

  • Detail

3056-33-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide

1.2 Other means of identification

Product number -
Other names N,9-Diacetylguanine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3056-33-5 SDS

3056-33-5Synthetic route

2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

acetic anhydride
108-24-7

acetic anhydride

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 160℃; for 18h;97%
In N,N-dimethyl-formamide at 160℃; for 2h; Acetylation;95%
for 16h; Heating;95%
acetic anhydride
108-24-7

acetic anhydride

A

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

B

1,2,3,5-tetraacetylribose
13035-61-5

1,2,3,5-tetraacetylribose

Conditions
ConditionsYield
Stage #1: acetic anhydride; G at 136℃; for 1h;
Stage #2: With trifluoroacetic acid at 60 - 100℃;
A 96%
B 86%
guanine powder

guanine powder

acetic anhydride
108-24-7

acetic anhydride

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Conditions
ConditionsYield
With acetic acid at 135℃; for 7.5h;95%
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

acetyl chloride
75-36-5

acetyl chloride

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Conditions
ConditionsYield
With pyridine; dmap at -5 - 20℃;91.7%
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

acetic anhydride
108-24-7

acetic anhydride

A

N,N'-diacetylguanine
137226-08-5

N,N'-diacetylguanine

B

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Conditions
ConditionsYield
In acetic acid at 140℃; for 18h; Yield given. Title compound not separated from byproducts;
2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Conditions
ConditionsYield
With acetic anhydride
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

N-(6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide
19962-37-9

N-(6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide

Conditions
ConditionsYield
In ethanol; water for 2h; Reflux;98%
With ethanol In water Reflux;
In ethanol; water at 80℃;12 g
2-acetoxyethyl acetoxymethyl ether
59278-00-1

2-acetoxyethyl acetoxymethyl ether

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one
75128-73-3

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one

Conditions
ConditionsYield
at 105℃; for 80h;95.1%
With toluene-4-sulfonic acid In toluene at 110℃; Temperature; Large scale;94.3%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

2-amino-1,9-dihydro-6H-purin-6-one
73-40-5

2-amino-1,9-dihydro-6H-purin-6-one

Conditions
ConditionsYield
With sodium hydroxide In water for 1h; Heating;95%
diphenylcarbamic chloride
83-01-2

diphenylcarbamic chloride

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

N2-acetyl-O6-(diphenylcarbamoyl)guanine
112233-74-6

N2-acetyl-O6-(diphenylcarbamoyl)guanine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In pyridine for 1h; Ambient temperature;92%
Stage #1: diphenylcarbamic chloride; 2,9-diacetylguanine With pyridine; N-ethyl-N,N-diisopropylamine for 4h;
Stage #2: In ethanol; water at 70℃; for 3.5h;
91%
With ethanol; N-ethyl-N,N-diisopropylamine 1.) pyridine, room temp., 1 h, 2.) heating; Yield given. Multistep reaction;
Stage #1: diphenylcarbamic chloride; 2,9-diacetylguanine With pyridine; N-ethyl-N,N-diisopropylamine at 20℃; for 2h;
Stage #2: With ethanol; water for 1.5h; Heating / reflux;
2-(acetoxymethoxy)-1,3-propanediyl diacetate
86357-13-3

2-(acetoxymethoxy)-1,3-propanediyl diacetate

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

9-(1,3-diacetoxy-2-propoxymethyl)-N2-acetylguanine
86357-14-4

9-(1,3-diacetoxy-2-propoxymethyl)-N2-acetylguanine

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In N,N-dimethyl-formamide at 100℃; for 10h; Solvent; Temperature; Microwave irradiation;85.3%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

2-amino-6-chloropurine
10310-21-1

2-amino-6-chloropurine

Conditions
ConditionsYield
With trichlorophosphate In 1,2-dichloro-ethane at 80℃;84%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

2-Amino-6-chloropurin
10310-21-1

2-Amino-6-chloropurin

Conditions
ConditionsYield
With trichlorophosphate In 1,2-dichloro-ethane; PEG-2000 at 80℃; for 6.33333h;84%
2-(4-nitrophenyl)ethanol
100-27-6

2-(4-nitrophenyl)ethanol

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

N2,N9-diacetyl-O6-2-(4-nitrophenyl)ethylguanine
917376-69-3

N2,N9-diacetyl-O6-2-(4-nitrophenyl)ethylguanine

Conditions
ConditionsYield
With ethyl azodicarboxylate; triphenylphosphine In 1,4-dioxane for 24h;80%
With triphenylphosphine; diethylazodicarboxylate In 1,4-dioxane at 20℃; Condensation; Mitsunobu reaction;
2-acetoxyethyl acetoxymethyl ether
59278-00-1

2-acetoxyethyl acetoxymethyl ether

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine
91702-60-2

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine

Conditions
ConditionsYield
With titanium tetrachloride In acetic acid at 10 - 15℃; for 6h;65.4%
2-(4-nitrophenyl)ethanol
100-27-6

2-(4-nitrophenyl)ethanol

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

N2-acetyl-O6-(2-(p-nitrophenyl)ethyl)guanine
218152-30-8

N2-acetyl-O6-(2-(p-nitrophenyl)ethyl)guanine

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate at 20℃;64%
trans-2,3-Dichlorotetrahydrofuran
3511-19-1, 13129-90-3, 29120-50-1, 106445-14-1

trans-2,3-Dichlorotetrahydrofuran

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

trans-9-(3-chlorotetrahydrofuran-2-yl)guanine
106445-17-4

trans-9-(3-chlorotetrahydrofuran-2-yl)guanine

Conditions
ConditionsYield
With Bis(p-nitrophenyl) phosphate In sulfolane at 100℃; for 16h;59.7%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

1,3-dipivaloyloxy-2-((methylsulfinyl)methoxy)propane
100675-34-1

1,3-dipivaloyloxy-2-((methylsulfinyl)methoxy)propane

A

2,2-Dimethyl-propionic acid 2-(2-acetylamino-6-oxo-1,6-dihydro-purin-7-ylmethoxy)-3-(2,2-dimethyl-propionyloxy)-propyl ester
119824-58-7

2,2-Dimethyl-propionic acid 2-(2-acetylamino-6-oxo-1,6-dihydro-purin-7-ylmethoxy)-3-(2,2-dimethyl-propionyloxy)-propyl ester

B

N2-acetyl-9-((1,3-pivaloyloxy-2-propoxy)methyl)guanine
100675-29-4

N2-acetyl-9-((1,3-pivaloyloxy-2-propoxy)methyl)guanine

Conditions
ConditionsYield
With toluene-4-sulfonic acid In dimethyl sulfoxide; N,N-dimethyl-formamide at 105℃; for 42h;A 17%
B 44.5%
1-benzyloxy-3-benzyloxy-2acetyloxymethoxypropane
84245-11-4

1-benzyloxy-3-benzyloxy-2acetyloxymethoxypropane

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

A

N2-acetyl-7-<<1,3-bis(benzyloxy)-2-propoxy>methyl>guanine
84222-48-0

N2-acetyl-7-<<1,3-bis(benzyloxy)-2-propoxy>methyl>guanine

B

N2-acetyl-9-<<1,3-bis(benzyloxy)-2-propoxy>methyl>guanine
82410-30-8

N2-acetyl-9-<<1,3-bis(benzyloxy)-2-propoxy>methyl>guanine

Conditions
ConditionsYield
With toluene-4-sulfonic acid In sulfolane at 95℃; for 72h; Yield given;A n/a
B 31%
With toluene-4-sulfonic acid In sulfolane at 95℃; for 72h; Yields of byproduct given;A n/a
B 31%
With toluene-4-sulfonic acid In sulfolane at 95℃; for 85h;A n/a
B 31%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Acetic acid 5-(diethoxy-phosphoryl)-pentyloxymethyl ester
174538-08-0

Acetic acid 5-(diethoxy-phosphoryl)-pentyloxymethyl ester

[5-(2-Acetylamino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-pentyl]-phosphonic acid diethyl ester
174538-32-0

[5-(2-Acetylamino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-pentyl]-phosphonic acid diethyl ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid In acetonitrile for 96h; Heating;31%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

(+/-)-1-(acetoxymethoxy)-2,3-diacetoxypropane
96429-67-3

(+/-)-1-(acetoxymethoxy)-2,3-diacetoxypropane

A

(+/-)-N2-acetyl-7-<(2,3-diacetoxy-1-propoxy)methyl>guanine
96429-69-5

(+/-)-N2-acetyl-7-<(2,3-diacetoxy-1-propoxy)methyl>guanine

B

(+/-)-N2-acetyl-9-<(2,3-diacetoxy-1-propoxy)methyl>guanine
96429-68-4

(+/-)-N2-acetyl-9-<(2,3-diacetoxy-1-propoxy)methyl>guanine

Conditions
ConditionsYield
With ethanesulfonic acid at 155 - 160℃; for 1.25h;A n/a
B 29%
1,3-DIOXOLANE
646-06-0

1,3-DIOXOLANE

acetic anhydride
108-24-7

acetic anhydride

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

A

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one
75128-73-3

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one

B

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine
91702-60-2

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine

Conditions
ConditionsYield
With toluene-4-sulfonic acid; acetic acid In toluene at 120℃; for 2.5h;A 29%
B 29%
Acetic acid 2-(2-oxo-propoxy)-ethyl ester
102728-65-4

Acetic acid 2-(2-oxo-propoxy)-ethyl ester

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

A

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one
75128-73-3

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one

B

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine
91702-60-2

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine

Conditions
ConditionsYield
With toluene-4-sulfonic acid 1.) 120-125 deg C, 2.) 150 deg C, 45 min;A 27%
B 22%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Acetic acid 2-acetoxymethoxy-3,3,3-trifluoro-propyl ester
181183-09-5

Acetic acid 2-acetoxymethoxy-3,3,3-trifluoro-propyl ester

A

Acetic acid 2-(2-acetylamino-6-oxo-1,6-dihydro-purin-7-ylmethoxy)-3,3,3-trifluoro-propyl ester

Acetic acid 2-(2-acetylamino-6-oxo-1,6-dihydro-purin-7-ylmethoxy)-3,3,3-trifluoro-propyl ester

B

Acetic acid 2-(2-acetylamino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-3,3,3-trifluoro-propyl ester

Acetic acid 2-(2-acetylamino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-3,3,3-trifluoro-propyl ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid at 145℃; for 16h;A 14%
B 22%
1,3-DIOXOLANE
646-06-0

1,3-DIOXOLANE

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

A

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one
75128-73-3

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one

B

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine
91702-60-2

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine

Conditions
ConditionsYield
With acetic anhydride; toluene-4-sulfonic acid In acetic acid for 1h; Heating;A 18%
B 2.3%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

Acetic acid 6-(diethoxy-phosphoryl)-hexyloxymethyl ester
174538-09-1

Acetic acid 6-(diethoxy-phosphoryl)-hexyloxymethyl ester

[6-(2-Acetylamino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-hexyl]-phosphonic acid diethyl ester
174538-33-1

[6-(2-Acetylamino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-hexyl]-phosphonic acid diethyl ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid In acetonitrile for 96h; Heating;14%
2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

diethyl <4-(acetoxymethoxy)butyl>phosphonate
174538-07-9

diethyl <4-(acetoxymethoxy)butyl>phosphonate

diethyl <4-<(2-acetamido-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy>butyl>phosphonate
174538-31-9

diethyl <4-<(2-acetamido-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy>butyl>phosphonate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In acetonitrile for 96h; Heating;12%
trans-2,3-Dichlorotetrahydrofuran
3511-19-1, 13129-90-3, 29120-50-1, 106445-14-1

trans-2,3-Dichlorotetrahydrofuran

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

trans-N2-acetyl-9-(3-chlorotetrahydrofuran-2-yl)guanine
106445-16-3

trans-N2-acetyl-9-(3-chlorotetrahydrofuran-2-yl)guanine

trans-N2-acetyl-7-(3-chlorotetrahydrofuran-2-yl)guanine
106445-15-2

trans-N2-acetyl-7-(3-chlorotetrahydrofuran-2-yl)guanine

Conditions
ConditionsYield
With Bis(p-nitrophenyl) phosphate In N,N-dimethyl-formamide 1) 90 to 95 deg C, 1 h, 2) RT, 16 h;A 11%
B 10.9%
allyloxymethyl acetate
98485-52-0

allyloxymethyl acetate

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

A

7-allyloxymethylguanine

7-allyloxymethylguanine

B

9-allyloxymethylguanine

9-allyloxymethylguanine

Conditions
ConditionsYield
With ammonia; toluene-4-sulfonic acid 1.) DMSO, from 95 deg C to 100 deg C, 40 h, 2.) MeOH, RT, 24 h; Yield given. Multistep reaction. Yields of byproduct given. Title compound not separated from byproducts;
With ammonia; toluene-4-sulfonic acid 1.) DMSO, from 95 deg C to 100 deg C, 40 h, 2.) MeOH, RT, 24 h; Yield given. Multistep reaction. Yields of byproduct given;
allyloxymethyl acetate
98485-52-0

allyloxymethyl acetate

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

A

7-allyloxymethyl-N-acetylguanine

7-allyloxymethyl-N-acetylguanine

B

9-allyloxymethyl-N-acetylguanine

9-allyloxymethyl-N-acetylguanine

Conditions
ConditionsYield
With toluene-4-sulfonic acid In dimethyl sulfoxide at 95 - 100℃; for 40h; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
With toluene-4-sulfonic acid In dimethyl sulfoxide at 95 - 100℃; for 40h; Yield given. Yields of byproduct given;
2-methoxy-ethanol
109-86-4

2-methoxy-ethanol

acetic anhydride
108-24-7

acetic anhydride

2,9-diacetylguanine
3056-33-5

2,9-diacetylguanine

A

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one
75128-73-3

2-acetylamino-9-(2-acetoxyethoxymethyl)purine-6-one

B

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine
91702-60-2

7-<(2-acetoxyethoxy)methyl>-N2-acetylguanine

Conditions
ConditionsYield
With toluene-4-sulfonic acid 1.) AcOH, 2.) toluene, reflux, 16 h; Yield given. Multistep reaction. Yields of byproduct given;

3056-33-5Relevant academic research and scientific papers

Voltammetric study of the affinity of divalent heavy metals for guanine-functionalized iron oxide nanoparticles

Sawan, Simona,Hamze, Khalil,Youssef, Ali,Boukarroum, Rayyan,Bouhadir, Kamal,Errachid, Abdelhamid,Maalouf, Rita,Jaffrezic-Renault, Nicole

, p. 229 - 240 (2021/02/12)

In this study, a novel nanobiomaterial based on (3-aminopropyl)triethoxysilane (APTES)-coated iron oxide (Fe3O4) nanoparticles functionalized with newly synthesized guanine hydrazide (GH) was elaborated. A boron-doped diamond electrode coated with GH-APTES–Fe3O4 nanoparticles was used to assess the interaction of heavy metal ions with guanine hydrazide. The adsorption isotherms were electrochemically investigated and it was shown that the adsorption capacity of the nanoparticles towards heavy metals decreased in the following order: Cu2+ > Pb2+ > Cd2+. From the calibration curves, the sensitivities of detection were as follows: 171.6 μA/μM for Cu(II), 156 μA/μM for Pb(II), and 101.4 μA/μM for Cd(II). Graphic abstract: [Figure not available: see fulltext.].

Preparation method of N2,9-diacetylguanine

-

Paragraph 0027; 0028; 0029; 0030; 0031; 0032, (2017/06/02)

The invention belongs to the technical field of chemistry, and in particular, relates to a preparation method of N2,9-diacetylguanine. The method comprises the steps: A, dissolving guanine in pyridine under the condition of stirring, then adding a 4-dimethylamino pyridine DMAP catalyst into a guanine pyridine solution, cooling to -5+/-1 DEG C, slowly dropping an acylating agent acetyl chloride, and in the dropping process, controlling the temperature to be lower than 10 DEG C; and after dropping is finished, carrying out a reaction for 2-4 h at room temperature, to obtain an X1-containing reaction liquid; B, heating the X1 reaction liquid, carrying out reduced pressure distillation to remove substances X2 and X3, and separating out an X1-containing solid; C, washing the X1-containing solid obtained in the step B with distilled water, and filtering to remove X4 and X5; and D, dissolving the X1-containing solid obtained in the step C in an acetic acid solution through stirring, and filtering to remove an undissolved substance X6, to obtain an X1-containing filtrate. The total yield of N2,9-diacetylguanine reaches 90.2%, and the purity of the product reaches 99.5%.

Small Molecules in the Cone Snail Arsenal

Neves, Jorge L. B.,Lin, Zhenjian,Imperial, Julita S.,Antunes, Agostinho,Vasconcelos, Vitor,Olivera, Baldomero M.,Schmidt, Eric W.

supporting information, p. 4933 - 4935 (2015/11/03)

Cone snails are renowned for producing peptide-based venom, containing conopeptides and conotoxins, to capture their prey. A novel small-molecule guanine derivative with unprecedented features, genuanine, was isolated from the venom of two cone snail species. Genuanine causes paralysis in mice, indicating that small molecules and not just polypeptides may contribute to the activity of cone snail venom.

Synthesis and biological activities of O6-alkylguanine derivatives

Hu, Yu Lin,Ge, Qiang,Lu, Ming,Lu, Hong Fei

experimental part, p. 425 - 432 (2012/01/13)

The synthesis of some biologically active O6-alkylguanine derivatives was achieved by alkoxylation of 2-amino-6-chloropurine with sodium alkoxides in polar aprotic solvent (DMSO) conditions. The starting material 2-amino-6-chloropurine was prepared by chlorination of 2,9-diacetylguanine (obtained from acetylation of commercially available guanine) by PEG-2000 phase transfer catalysis. The structures of the products were deduced from elemental analysis and spectral data (IR, 1H NMR, and mass spectra). All the title compounds were screened for their antifungal activities, and some of the compounds showed promising activities.

Synthesis of some biologically active halogenopurines

Hu, Yu Lin,Liu, Xiang,Lu, Ming,Ge, Qiang,Liu, Xiao Bin

experimental part, p. 429 - 436 (2010/12/29)

A series of some biologically active halogenopurines were synthesized from commercially available guanine (1). The reaction of guanine with acetic anhydride yielded 2,9-diacetylguanine (2-1) by acetylation reaction. Further treatment of 2-1 with POCl3 by PEG-2000 phase transfer catalysis furnished the important compound 3a, then 2-amino-6-halogenopurines (3b-d) were obtained through chlorine-exchange halogenations between KX and 3a by TPPB phase transfer catalyst. Further, 2-halogenopurines (2-2a-d, 4-2a-d, 5a-d) were efficiently prepared from 2-amino-6-substituted purines (1, 3a, 4-1) via a diazotization catalyzed by their corresponding CuX, and some new compounds 2-2a, 2-2c, 2-2d, 4-2c, 4-2d, 5b, 5c and 5d have been discovered. The structures of synthesized compounds were mainly established on the basis of their elemental analysis, 1H NMR, as well as their mass spectral data. All the title compounds were screened for their antifungal activities, and some of the compounds showed promising activity.

Guanine-Containing DNA Minor-Groove binders

Pulido, Daniel,Sanchez, Albert,Robles, Jordi,Pedroso, Enrique,Grandas, Anna

experimental part, p. 1398 - 1406 (2009/08/07)

Solid-phase procedures have been used to prepare six di-pyrrole-containing DNA ligands that combine (guanin-9-yl)-acetyl, (guanin-7-yl)acetyl or acetyl moieties at the N-terminal end and two lysines or a (dimethylamino)propyl group at the C terminus. Inspection of their DNA-stabilizing properties by UV-monitored thermal denaturation experiments showed that the ligand incorporating the (guanin-9-yl)acetyl group and the (dimethylamino)propyl tail had the highest duplex-stabilizing effects. Wiley-VCH Verlag GmbH & Co, KGaA.

Engineering a selective small-molecule substrate binding site into a deoxyribozyme

Hoebartner, Claudia,Silverman, Scott K.

, p. 7420 - 7424 (2008/09/18)

A small goal: An RNA ligase deoxyribozyme is engineered to accept a small-molecule NTP substrate in a multiple-turnover fashion. Selective binding is enforced by hydrogen bonding, and structural preorganization within the NTP itself is important for its efficient utilization as a substrate. This study points the way toward a broader use of small-molecule substrates with nucleic acid enzymes. (Figure Presented)

Positively-charged peptide nucleic acid analogs with improved properties

-

Page/Page column 8-9, (2008/06/13)

The present invention relates to novel types of peptide nucleic acids (PNAS) with improved properties. In particular, it relates to positively charged PNA units having an ethylene linker between the backbone and the nucleobase, to oligonucleotide analogs comprising these units, to oligomers comprising these units, and to the use of positively charged PNAs as novel delivery agents with therapeutic and diagnostic applications including for antisense therapy.

A novel approach to the synthesis of the purine anti-viral agent gancyclovir

Sariri, Reyhaneh,Khalili, Gholamhosein

, p. 651 - 654 (2007/10/03)

The aim of this research is to synthesize gancyclovir, a purine anti-viral drug in large scale via simple intermediates. Reaction of guanine 1 with acetic anhydride followed by the attachment of the 2-O-acetoxymethyl-1,3-di-O-benzyl glycerol 3 as a side chain, subsequently lead to the production of N2acetyl-9-(1,3dibenzyloxy-2-propoxymethyl)guanine 6 and N2, acetyl-9-(1,3-dihydroxy-2-propoxymethyl)guanine 7 and finally synthesizing gancyclovir 8. Among many pathways to the synthesis of purine derivatives, our four step procedure results in good yield and is proved to be an economic way of large scale synthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3056-33-5